Please login to the form below

Not currently logged in
Email:
Password:

AlixPartners appoints new managing director

Dr Andreas Vogt takes up new role at the global business advisory firm

Dr Andreas VogtDr Andreas Vogt has joined AlixPartners' healthcare and life sciences team in a Zurich-based role that focuses on supporting medtech and healthcare companies through performance improvement and large transformational projects.

Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies.

Simon Freakley, CEO at AlixPartners, said: “He has substantial experience in this industry, both as a strategy consultant and as a physician, and I am confident that his expertise will prove invaluable as we continue to strengthen our European healthcare and life sciences practice.”

Prior to his experience at Deloitte Consulting, Vogt served Roland Berger Strategy Consultants as a member of the management team.

Beatrix Moarth, managing director and country head for Switzerland at AlixPartners, said: “He has worked in a variety of consulting positions and has an excellent network.

“I am confident that Andreas will be an integral part in supporting clients within the healthcare and life sciences field of business as we continue to grow.”

23rd March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics